...
首页> 外文期刊>Gynecologic and obstetric investigation >Prospective Evaluation of a Panel of Plasma Cytokines and Chemokines as Potential Markers of Pelvic Endometriosis in Symptomatic Women
【24h】

Prospective Evaluation of a Panel of Plasma Cytokines and Chemokines as Potential Markers of Pelvic Endometriosis in Symptomatic Women

机译:一组血浆细胞因子和趋化因子作为有症状女性盆腔子宫内膜异位症的潜在标志物的前瞻性评估

获取原文
获取原文并翻译 | 示例

摘要

Background: Endometriosis is a chronic inflammatory disease for which no accurate peripheral diagnostic marker is available. Many cytokines and chemokines have been found altered in the plasma and peritoneal fluid of women with endometriosis compared to healthy controls, but little is known about their diagnostic utility to confirm or discard endometriosis among symptomatic women. Objective: The study aims to assess the diagnostic value of a panel of plasma cytokines and chemokines to detect endometriosis in women undergoing laparoscopy for gynecological complains. Methods: We performed a prospective cohort study evaluating simultaneously plasma concentrations of interleukin (IL)-2, IL-4, IL-6, IL-10, MCP-1/CCL2, IP-10/CXCL10 and eotaxin/CCL11 in 75 symptomatic women (chronic pelvic pain, infertility or ovarian cyst) submitted to laparoscopy. Assays were performed by Cytometric Bead Array System. Endometriosis was confirmed by histopathological examination of surgical specimens. Results: Plasma IL-2, IL-4, IL-6, IL-10, MCP-1/CCL2, IP-10/CXCL10 and eotaxin/CCL11 concentrations were not able to distinguish the women who eventually were diagnosed with endometriosis. Conclusion: Although previously shown to be altered in women with endometriosis compared to healthy women, the tested cytokines and chemokines were not useful to predict the presence of endometriosis among symptomatic women. This finding suggests that inflammatory markers modified by endometriosis may also be altered by other conditions associated with similar symptoms, which limits their use in clinical practice. (C) 2016 S. Karger AG, Basel
机译:背景:子宫内膜异位症是一种慢性炎症性疾病,尚无准确的外周诊断标志物。与健康对照组相比,已发现子宫内膜异位症妇女的血浆和腹膜液中有许多细胞因子和趋化因子发生了改变,但对于它们在有症状女性中确认或丢弃子宫内膜异位症的诊断作用知之甚少。目的:该研究旨在评估一组血浆细胞因子和趋化因子在妇科腹腔镜检查妇女中检测子宫内膜异位的诊断价值。方法:我们进行了一项前瞻性队列研究,同时评估了75例有症状的白细胞介素(IL)-2,IL-4,IL-6,IL-10,MCP-1 / CCL2,IP-10 / CXCL10和嗜酸性粒细胞趋化因子/ CCL11的血浆浓度腹腔镜检查的女性(慢性盆腔疼痛,不育症或卵巢囊肿)。通过细胞计数珠阵列系统进行测定。子宫内膜异位症通过手术标本的组织病理学检查证实。结果:血浆IL-2,IL-4,IL-6,IL-10,MCP-1 / CCL2,IP-10 / CXCL10和嗜酸性粒细胞趋化因子/ CCL11的浓度无法区分最终被诊断为子宫内膜异位的女性。结论:尽管以前显示子宫内膜异位症的女性比健康女性有所改变,但测试的细胞因子和趋化因子并不能用来预测有症状女性的子宫内膜异位症的存在。这一发现表明,由子宫内膜异位症修饰的炎性标志物也可能会因与类似症状相关的其他状况而改变,这限制了它们在临床实践中的使用。 (C)2016 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号